CRISIL has reaffirmed ‘AAA/Stable’ rating assigned to Dabur India’s long term bank facilities and non-convertible debenture programme aggregating to Rs 125 crore and Rs 200 crore respectively. Meanwhile, the credit rating agency has reaffirmed ‘A1+’ rating assigned to company’s short term debt programme aggregating to Rs 200 crore.
Dabur India has business interests in healthcare, personal care and food products. The company’s portfolio comprises of over 350 products, covering a wide range in health and personal care. It has manufacturing facilities in ten countries including India, UAE, Nepal, Bangladesh, Egypt, and Nigeria.